Treatment effects of fingolimod in multiple sclerosis: Selective changes in peripheral blood lymphocyte subsets

BACKGROUND: Treatment with fingolimod reduces inflammation in multiple sclerosis (MS) by inhibiting lymphocyte egress from lymph nodes. We aimed to map, in detail, the alterations in peripheral blood lymphocyte subpopulations in relation to clinical outcome in MS patients treated with fingolimod. ME...

Descripción completa

Detalles Bibliográficos
Autores principales: Hjorth, Maria, Dandu, Nicolae, Mellergård, Johan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6996838/
https://www.ncbi.nlm.nih.gov/pubmed/32012202
http://dx.doi.org/10.1371/journal.pone.0228380

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6996838/
https://www.ncbi.nlm.nih.gov/pubmed/32012202
http://dx.doi.org/10.1371/journal.pone.0228380

Ejemplares similares